Aetna Unveils 2026 Medicare Advantage Plans with Expanded Benefits
Aetna announces its 2026 Medicare Advantage plans featuring expanded supplemental benefits, enhanced Special Needs Plans, and affordable prescription drug coverage across 43 states.
Aetna announces its 2026 Medicare Advantage plans featuring expanded supplemental benefits, enhanced Special Needs Plans, and affordable prescription drug coverage across 43 states.
Alignment Health Plan announces its 2026 Medicare Advantage portfolio with 68 plans across five states, featuring expanded special needs coverage and competitive Part B rebates.
Essence Healthcare announces 2026 Medicare Advantage plans in Central Arkansas, offering high-quality, affordable coverage with strong CMS star ratings and added member benefits.
Humana’s 2026 Medicare Advantage and Prescription Drug Plans emphasize simplicity, stability, and expanded access, with lowered premiums and enhanced benefits for Medicare beneficiaries nationwide.
Gain key insights on the Medicare Annual Election Period (AEP) and Pre-AEP phases, critical for managing Medicare Advantage and Prescription Drug Plan enrollment and changes. Understand compliance, timing, and beneficiary engagement.
Special Needs Plans (SNPs) enrollment now constitutes 21% of Medicare Advantage, driven by regulatory changes and payer concentration, amid overall MA market growth challenges.
Kettering Health in Ohio ends contracts with Medicare Advantage insurers Humana and Devoted Health due to payment and administrative issues, impacting patient plan options for 2026.
Solange De Lahongrais appointed as president of Puerto Rico Medicaid and Medicare Advantage Products Association, focusing on federal funding parity and program sustainability ahead of Medicaid funding expiration in 2027.
Medicare Advantage plans saw a slower growth in administrative expenses in 2024, with detailed insights from the Sherlock Benchmarks revealing trends in cost drivers and plan management effectiveness.
SelectQuote faces a DOJ investigation and investor lawsuit over alleged deceptive Medicare Advantage sales practices, triggering a sharp stock decline and regulatory scrutiny.